Daniel Stauder
Stock Analyst at Citizens JMP
(4.25)
# 1,439
Out of 4,609 analysts
43
Total ratings
56.4%
Success rate
23.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintained: Buy | $53 → $48 | $26.57 | +80.65% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $118 → $127 | $80.82 | +57.14% | 11 | May 6, 2026 | |
| ATRC AtriCure | Maintained: Buy | $60 → $52 | $39.49 | +31.68% | 15 | Feb 18, 2026 | |
| STXS Stereotaxis | Initiated Coverage: Buy | $4 | $1.36 | +194.12% | 1 | Dec 16, 2025 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $2.25 | n/a | 6 | Mar 5, 2025 |
Artivion
May 8, 2026
Maintained: Buy
Price Target: $53 → $48
Current: $26.57
Upside: +80.65%
LeMaitre Vascular
May 6, 2026
Maintained: Buy
Price Target: $118 → $127
Current: $80.82
Upside: +57.14%
AtriCure
Feb 18, 2026
Maintained: Buy
Price Target: $60 → $52
Current: $39.49
Upside: +31.68%
Stereotaxis
Dec 16, 2025
Initiated Coverage: Buy
Price Target: $4
Current: $1.36
Upside: +194.12%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $2.25
Upside: n/a